Related references
Note: Only part of the references are listed.Use of the 13-valent pneumococcal conjugate vaccine in infants and young children
Nicola Principi et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Novel Protein-Based Pneumococcal Vaccines Administered with the Th1-Promoting Adjuvant IC31 Induce Protective Immunity against Pneumococcal Disease in Neonatal Mice
Thorunn Asta Olafsdottir et al.
INFECTION AND IMMUNITY (2012)
Serotype replacement in disease after pneumococcal vaccination
Daniel M. Weinberger et al.
LANCET (2011)
Bacterial Meningitis in the United States, 1998-2007
Michael C. Thigpen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Healthcare utilization and cost of pneumococcal disease in the United States
Susan S. Huang et al.
VACCINE (2011)
Secretory-IgA Antibodies Play an Important Role in the Immunity to Streptococcus pneumoniae
Yoshiko Fukuyama et al.
JOURNAL OF IMMUNOLOGY (2010)
Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines
Tomonori Nochi et al.
NATURE MATERIALS (2010)
Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe
Markus Rose et al.
EXPERT REVIEW OF VACCINES (2009)
Interleukin-17A and Interleukin-17F: A Tale of Two Cytokines
Patricia J. Dubin et al.
IMMUNITY (2009)
PspA Family Fusion Proteins Delivered by Attenuated Salmonella enterica Serovar Typhimurium Extend and Enhance Protection against Streptococcus pneumoniae
Wei Xin et al.
INFECTION AND IMMUNITY (2009)
Cutting Edge: Lung Mucosal Th17-Mediated Responses Induce Polymeric Ig Receptor Expression by the Airway Epithelium and Elevate Secretory IgA Levels
Zeina Jaffar et al.
JOURNAL OF IMMUNOLOGY (2009)
Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus
Agnes Doreau et al.
NATURE IMMUNOLOGY (2009)
Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis
Heather E. Hsu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Intranasal immunization with a mixture of PspA and a Toll-like receptor agonist induces specific antibodies and enhances bacterial clearance in the airways of mice
Keita Oma et al.
VACCINE (2009)
Self-assembled cationic nanogels for intracellular protein delivery
Hirohito Ayame et al.
BIOCONJUGATE CHEMISTRY (2008)
Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era
Ener Cagri Dinleyici et al.
EXPERT REVIEW OF VACCINES (2008)
Interleukin-17A mediates acquired immunity to pneumococcal colonization
Ying-Jie Lu et al.
PLOS PATHOGENS (2008)
Fusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition
M. Darrieux et al.
INFECTION AND IMMUNITY (2007)
Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage
Rosalyn J. Singleton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
TH-17 cells in the circle of immunity and autoimmunity
Estelle Bettelli et al.
NATURE IMMUNOLOGY (2007)
Pneumococcal surface protein A (PspA) family distribution among clinical isolates from adults over 50 years of age collected in seven countries
SK Hollingshead et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Reduction of astrogliosis by early treatment of pneumococcal meningitis measured by simultaneous imaging, in vivo, of the pathogen and host response
JL Kadurugamuwa et al.
INFECTION AND IMMUNITY (2005)
In vitro cytotoxicity of carcinoma cells with 111In-labeled antibodies to HER-2
RB Michel et al.
MOLECULAR CANCER THERAPEUTICS (2005)
CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization
R Malley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Invasive Streptococcus pneumoniae isolates from Argentinian children:: serotypes, families of pneumococcal surface protein A (PspA) and genetic diversity
M Mollerach et al.
EPIDEMIOLOGY AND INFECTION (2004)
Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland
M Mutsch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Typing of pneumococcal surface protein A (PspA) in Streptococcus pneumoniae isolated during epidemiological surveillance in Brazil:: towards novel pneumococcal protein vaccines
MCC Brandileone et al.
VACCINE (2004)
Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface
B Ren et al.
INFECTION AND IMMUNITY (2004)
Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae
DE Briles et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Initiation of NALT organogenesis is independent of the IL-7R, LTβR, and NIK signaling pathways but requires the Id2 gene and CD3-CD4+CD45+ cells
S Fukuyama et al.
IMMUNITY (2002)
Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon
KP Francis et al.
INFECTION AND IMMUNITY (2001)
The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae
DE Briles et al.
VACCINE (2000)
Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA
DE Briles et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Cutting edge: The mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues
FW van Ginkel et al.
JOURNAL OF IMMUNOLOGY (2000)
Diversity of PspA:: Mosaic genes and evidence for past recombination in Streptococcus pneumoniae
SK Hollingshead et al.
INFECTION AND IMMUNITY (2000)
Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules
GS Nabors et al.
VACCINE (2000)
Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae
DE Briles et al.
INFECTION AND IMMUNITY (2000)
Share Paper
